| 0 |
Close |
| 1 |
Substance |
| 2 |
Recall period |
| 3 |
Age |
| 4 |
Gender |
| 5 |
prevalence of drug use |
| 6 |
Percent |
| 7 |
Breakdown by substance |
| 8 |
prevalence all available countries |
| 9 |
Trends |
| 11 |
Males and females |
| 14 |
Country |
| 15 |
|
| 16 |
About the data |
| 50 |
Years |
| 17 |
Currently not available for individual countries |
| 101 |
prevalence of cannabis use |
| 102 |
prevalence of cocaine use |
| 103 |
prevalence of MDMA use |
| 104 |
prevalence of amphetamines use |
| 105 |
prevalence of methamphetamine use |
| 231 |
Gender breakdown: all treatment entrants |
| 232 |
Mean age: all treatment entrants |
| 233 |
Client status – number of clients |
| 234 |
First-time entrants |
| 235 |
Previously treated entrants |
| 236 |
Unknown status |
| 237 |
Route of administration: all treatment entrants (%) |
| 238 |
Injecting |
| 239 |
Smoking/inhaling |
| 240 |
Eating/drinking |
| 241 |
Sniffing |
| 242 |
Other |
| 243 |
Frequency of use in the last month (%): all treatment entrants |
| 244 |
4 to 6 days per week |
| 245 |
2 to 3 days per week |
| 246 |
Once a week or less |
| 247 |
Not used in the last 30 days |
| 248 |
Trends in new treatment entrants |
| 249 |
Trends in all treatment entrants |
| 250 |
Cannabis market: data and trends |
| 260 |
Cannabis type |
| 261 |
Daily |
| 265 |
COVID-19 pandemic |
| 312 |
Geographical coverage (selected graphs) |
| 315 |
Number of seizures |
| 324 |
Price retail (EUR/g) (EU) |
| 325 |
Price wholesale (EUR/kg) (EU) |
| 330 |
Quantity seized (tonnes) |
| 332 |
Quantity seized |
| 335 |
Quantity seized (tablets) |
| 337 |
Quantity seized (million tablets) |
| 360 |
Cannabis type |
| 365 |
Substance |
| 370 |
Potency (%) |
| 372 |
Purity (%) |
| 374 |
Purity retail (%) (EU) |
| 375 |
Indexed trends, retail (2012=100) (EU) |
| 377 |
Indexed trends: price and purity, retail (2012=100) (EU) |
| 380 |
Indexed trends: purity, retail (2012=100) (EU) |
| 385 |
Trends in number of seizures |
| 386 |
Trends in quantity seized (kg) |
| 387 |
Trends in the number of MDMA seizures (all forms) |
| 388 |
Trends in the quantity of MDMA seized
Tablets (millions) |
| 390 |
Trends in the quantity of MDMA seized
Kilograms (powder/crystal) |
| 395 |
Trends in quantity seized (tonnes) |
| 397 |
Tonnes |
| 400 |
mg/1000 population/day |
| 450 |
Price retail (EUR/tablet) |
| 453 |
Price retail (EUR/g powder) |
| 455 |
Price wholesale (EUR/1000 tablets) |
| 460 |
Content retail (mg/tablet) |
| 465 |
Purity powder retail (%) |
| 470 |
Entrants for this substance as a share of all first-time treatment entrants |
| 490 |
Retail |
| 491 |
Wholesale |
| 495 |
Purity |
| 496 |
Potency |
| 500 |
cannabis |
| 510 |
cocaine |
| 520 |
amphetamine |
| 530 |
methamphetamine |
| 540 |
MDMA |
| 550 |
ketamine |
| 100200 |
Mean use: 4.3 days per week |
| 100201 |
Mean use 3.3 days per week |
